Isis Pharmaceuticals (ISIS) Reports Earnings: It’s A Beat
February 27, 2015 at 09:45 AM EST
Isis Pharmaceuticals, Inc. (ISIS) shares are up $2.21, or 3.28%, to $69.41 in early trading Friday after the company reported its fourth quarter earnings results. The firm reported non-GAAP earnings of $0.32 per share on revenues of $84.9 million, up 101.2% from a year ago. Analysts were expecting EPS of $0.04 on revenues of $74.58 […] View the full post at: Isis Pharmaceuticals (ISIS) Reports Earnings: It’s A Beat Related posts: JPMorgan Posts Better-than-Expected Results After-Hours Earnings (March 9) After-Hours Earnings (March 1)